Phase III trial of gabapentin alone or in conjunction with an antidepressant in the management of hot flashes in women who have inadequate control with an antidepressant alone: NCCTG N03C5.
- Citation:
- J Clin Oncol vol 25 (3) 308-12
- Year:
- 2007
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Program:
- CCP
- Primary Committee:
- Symptom Inter
- Sec. Committees:
- Pharmas:
- Grants:
- CA-25224, CA-35090, CA-35101, CA-35103, CA-35113, CA-35119, CA-35195, CA-35267, CA-35431, CA-37404, CA-37417, CA-63848, CA-63849
- Corr. Author:
- Authors:
- Charles L Loprinzi John W Kugler Debra L Barton Amylou C Dueck Loren K Tschetter Robert A Nelimark Ernie Porteza Balcueva Kelli N Burger Paul J Novotny Mark D Carlson Steven Fletcher Duane Steven W Corso David B Johnson Anthony J Jaslowski
- Networks:
- Study
- NCCTG-N03C5
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Adult, Aged, Aged, 80 and over, Amines, Anticonvulsants, Antidepressive Agents, Cyclohexanecarboxylic Acids, Drug Therapy, Combination, Female, Hot Flashes, Humans, Middle Aged, Treatment Outcome, gamma-Aminobutyric Acid